论文部分内容阅读
目的:通过分析临床资料探究甘精胰岛素联合瑞格列奈治疗2型糖尿病的疗效。方法:选取我院从2012年3月到2012年9月接收的30例T2DM患者为研究对象。综合分析这30例患者的临床资料和治疗方法。结果:30例T2DM患者全部取得较为良好的治疗效果。结论:甘精胰岛素联合瑞格列奈的强化降血糖治疗不仅能使T2DM患者血糖得到有效控制,还使其胰岛B细胞功能得到部分恢复。同时在门诊应用较方便,低血糖发生率低,患者依从性好。
Objective: To investigate the efficacy of insulin glargine combined with repaglinide in the treatment of type 2 diabetes mellitus by analyzing clinical data. Methods: Thirty patients with T2DM received in our hospital from March 2012 to September 2012 were selected as the study subjects. A comprehensive analysis of these 30 patients with clinical data and treatment. Results: All 30 patients with T2DM achieved better therapeutic effect. Conclusion: The intensive hypoglycemic treatment with glargine and repaglinide can not only effectively control blood glucose in T2DM patients, but also partially restore the islet B cell function. At the same time more convenient in the clinic, low incidence of hypoglycemia, patients with good compliance.